注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 自8月1日以来公司已连续25日进行回购，合计回购507.00万股，累计回购金额5.74亿港元。 其间该股累 计下跌0.10%。（数据宝） （文章来源：证券时报网） 恒生银行回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.09.04 | 21.00 | 113.700 | 112.900 | 2379.89 | | 2025.09.03 | 21.00 | 113.600 | 113.000 | 2377.55 | | 2025.09.02 | 21.00 | 113.300 | 111.300 | 2365.56 | | 2025.09.01 | 21.00 | 113.200 | 111.600 | 2356.76 | | 2025.08.29 | 21.00 | 112.500 | 111.500 | 2351.69 | | 2025.08.28 | 21.00 | 112.600 | 111.50 ...

Company News - Sun Hung Kai Properties (00016.HK) reported a revenue of HKD 79.721 billion for the fiscal year 2025, an increase of 11.5% year-on-year; net profit reached HKD 19.277 billion, up 1.2% year-on-year [2] - Sincere Watch International (00732.HK) recorded a net operating revenue of approximately HKD 11.011 billion for the first eight months, a decrease of 5.5% year-on-year; in August, the net operating revenue was about HKD 1.445 billion, down 6.5% year-on-year [2] Financial Activities - China Construction Bank (00939.HK) announced that CCB Financial Leasing plans to increase its capital by HKD 3 billion to CCB Shipping and Aviation [3] Pharmaceutical Developments - Heng Rui Medicine (01276.HK) received approval to conduct clinical trials for RSS0393 ointment, which can alleviate tissue damage and inflammation related to atopic dermatitis [4] - Heng Rui Medicine (01276.HK) also received approval for clinical trials of HRS-4729 injection, a tri-agonist for GLP-1R/GIPR/GCGR [4] Real Estate Sales Performance - China Overseas Land & Investment (00688.HK) reported a contracted sales amount of HKD 150.331 billion for the first eight months, a decline of 16.5% year-on-year; August contracted sales were HKD 18.33 billion, down 0.7% year-on-year [5] - Sunac China (01918.HK) recorded a contracted sales amount of approximately HKD 30.47 billion for the first eight months, a decrease of 13% year-on-year; August contracted sales were HKD 5.39 billion, down 26.7% year-on-year [5] - China Overseas Grand Oceans Group (00081.HK) reported a contracted sales amount of HKD 20.783 billion for the first eight months, a decline of 10.6% year-on-year; August contracted sales were HKD 2.133 billion, an increase of 6.1% year-on-year [5] - Gemdale Corporation (00535.HK) reported a total contracted sales of approximately HKD 7.588 billion for the first eight months, a decrease of 39% year-on-year; August contracted sales were HKD 608 million, down 52.9% year-on-year [5] - Hongyang Real Estate (01996.HK) reported a contracted sales amount of HKD 3.506 billion for the first eight months, a decrease of 42.2% year-on-year; August contracted sales were HKD 299 million, down 48.5% year-on-year [5] - Ronshine China Holdings (03301.HK) reported a contracted sales amount of approximately HKD 2.7 billion for the first eight months, a decline of 46.4% year-on-year; August contracted sales were about HKD 130 million, down 87.9% year-on-year [5] Share Buyback Activities - HSBC Holdings (00005.HK) repurchased 2.01 million shares at a cost of approximately HKD 200 million, with prices ranging from HKD 98.75 to HKD 100.3 [6] - Midea Group (00300.HK) repurchased 310,000 shares at a cost of approximately HKD 25.849 million, with prices ranging from HKD 83.3 to HKD 83.5 [6] - Hang Seng Bank (00011.HK) repurchased 210,000 shares at a cost of approximately HKD 23.799 million, with prices ranging from HKD 112.9 to HKD 113.7 [6] - MGM China Holdings (02282.HK) repurchased 1 million shares at a cost of approximately HKD 15.687 million, with prices ranging from HKD 15.58 to HKD 15.97 [6] Shareholding Changes - Kanglong Chemical (03759.HK) completed a share reduction plan, with a total of 26.6729 million shares reduced [6] - Sinopec Limited (00386.HK) canceled 67.624 million shares that had been repurchased [6]

Group 1 - Hang Seng Bank announced that its Executive Director and CEO, Ms. Diana Chan, will leave her position to join HSBC as Vice Chairman for Hong Kong, effective in October, pending regulatory approval [1][3] - Ms. Chan expressed her satisfaction in promoting measures for the sustainable development of Hang Seng Bank during her tenure, highlighting the bank's importance in Hong Kong's financial landscape [3] - The board of directors of Hang Seng Bank thanked Ms. Chan for her leadership, noting her success in driving sustainable growth in revenue and customer base, as well as enhancing brand recognition in the local community [3] Group 2 - Ms. Linda Li, who has held key positions in major Asian markets, will succeed Ms. Chan as Executive Director and CEO of Hang Seng Bank [1][3] - The Chairman of Hang Seng Bank, Mr. Cheng Wai Sun, stated that Ms. Li's extensive experience in driving business growth and transformation in various Asian markets makes her an ideal candidate to lead the bank to new heights [3] - Ms. Li's appointment is expected to help Hang Seng Bank achieve optimal performance [3]

智通财经APP讯，恒生银行(00011)发布公告，该公司于2025年9月4日斥资2379.89万港元回购21万股股 份，每股回购价格为112.9-113.7港元。 （原标题：恒生银行(00011)9月4日斥资2379.89万港元回购21万股） ...

Group 1 - The company, Hang Seng Bank, announced a share buyback plan on September 4, 2025, involving an expenditure of HKD 23.79 million to repurchase 210,000 shares [1] - The repurchase price per share is set between HKD 112.9 and HKD 113.7 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 恒生銀行有限公司 呈交日期： 2025年9月4日 第 2 頁 共 8 頁 v 1.3.0 FF305 | 12). | 購回以作註銷但尚未註銷之股份 | | 210,000 | 0.0112 % | HKD | 112.6458 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年9月2日 | | | | | | 13). | 購回以作註銷但尚未註銷之股份 | | 210,000 | 0.0112 % | HKD | 113.2165 | | | 變動日期 | 2025年9月3日 | | | | | | 14). | 購回以作註銷但尚未註銷之股份 | | 210,000 | 0.0112 % | HKD | 113.3282 | | | 變動日期 | 2025年9月4日 | | | | | FF305 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交 ...

恒生银行(00011)发布公告，施颖茵女士将于2025年10月退任该行政总裁，并调回香港上海汇丰银行有 限公司出任香港区副主席，为汇丰亚洲及中东地区联席行政总裁提供建议。施女士将不再出任该行执行 董事兼行政总裁，同时不再出任营运委员会主席及提名委员会成员。 汇丰香港行政总裁林慧虹女士将接任为该行执行董事兼行政总裁，自2025年10月起生效(相关委任须经 监管机构批准)。林女士同时将出任该行营运委员会主席及提名委员会成员。 ...

汇丰香港行政总裁林慧虹女士将接任为本行执行董事兼行政裁，自2025年10月起生效(相关委任须经监 管机构批准)。林女士同时将出任本行营运委员会主席及提名委员会成员。 格隆汇9月4日丨恒生银行(00011.HK)发布公告，施颖茵女士将于2025年10月退任本行行政裁，并调回香 港上海汇丰银行有限公司出任香港区副主席，为汇丰亚洲及中东地区联席行政总裁提供建议。施女士将 不再出任本行执行董事兼行政总裁，同时不再出任营运委员会主席及提名委员会成员。 ...

智通财经APP讯，恒生银行(00011)发布公告，施颖茵女士将于2025年10月退任该行政总裁，并调回香港 上海汇丰银行有限公司出任香港区副主席，为汇丰亚洲及中东地区联席行政总裁提供建议。施女士将不 再出任该行执行董事兼行政总裁，同时不再出任营运委员会主席及提名委员会成员。 汇丰香港行政总裁林慧虹女士将接任为该行执行董事兼行政总裁，自2025年10月起生效(相关委任须经 监管机构批准)。林女士同时将出任该行营运委员会主席及提名委员会成员。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損 失承擔任何責任。 股份代號: 11（港幣櫃台）及80011（人民幣櫃台） 董事會成員之變更 恒生銀行有限公司（「本行」）董事會（「董事會」）宣佈下列有關本行董事會成 員的未來變更。 施穎茵女⼠退任執行董事兼行政總裁 施穎茵女⼠將於2025年10月退任本行⾏政總裁，並調回香港上海滙豐銀⾏有限公 司出任香港區副主席，為滙豐亞洲及中東地區聯席⾏政總裁提供建議。施女⼠將不 再出任本⾏執⾏董事兼⾏政總裁，同時不再出任營運委員會主席及提名委員會成員。 施女⼠已確認彼與董事會之間並無任何意見分歧，且就彼退任⼀事，亦無任何事項 需要通知本⾏股東。 董事會衷心感謝施女⼠在任期間的傑出領導和努力不懈的敬業精神，為本⾏客户、 員工和股東作出卓越的貢獻，並祝願施女⼠⼀切順利。 林慧虹女⼠獲委任為執行董事兼行政總裁 滙豐香港⾏政總裁林慧虹女⼠將接任為本⾏執⾏董事兼⾏政總裁，自2025年10月 起生效（相關委任須經監管機構批准）。林女⼠同時將出任本 ...